Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France
Abstract This article is co-authored by a kidney transplant recipient and her nephrologist. By sharing her personal experience of the coronavirus disease 2019 (COVID-19) pandemic, the patient illustrates the concerns of immunocompromised patients during this unprecedented health crisis. She describe...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2024-03-01
|
Series: | Infectious Diseases and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40121-024-00941-2 |
_version_ | 1797233430247768064 |
---|---|
author | Elise Foudrat Sophie Caillard |
author_facet | Elise Foudrat Sophie Caillard |
author_sort | Elise Foudrat |
collection | DOAJ |
description | Abstract This article is co-authored by a kidney transplant recipient and her nephrologist. By sharing her personal experience of the coronavirus disease 2019 (COVID-19) pandemic, the patient illustrates the concerns of immunocompromised patients during this unprecedented health crisis. She describes the difficulties encountered at work, the omnipresent protective measures, and the need for appropriate information. The nephrologist, who follows a cohort of over 1700 kidney transplant recipients, recounts the medical team’s struggle to protect their vulnerable patients against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as a veritable succession of hopes and disappointments. She describes the management of immunosuppression in kidney transplant recipients, the deployment of the COVID-19 vaccination program with the finding of poor immune responses in many patients including those receiving immunosuppressant drugs after kidney transplant, and the first use of prophylactic monoclonal antibodies. From both the patient’s and the physician’s perspectives, the COVID-19 pandemic has required continuous adaptation. |
first_indexed | 2024-04-24T16:16:02Z |
format | Article |
id | doaj.art-f612e3739b264402aab2a294be1d5d24 |
institution | Directory Open Access Journal |
issn | 2193-8229 2193-6382 |
language | English |
last_indexed | 2024-04-24T16:16:02Z |
publishDate | 2024-03-01 |
publisher | Adis, Springer Healthcare |
record_format | Article |
series | Infectious Diseases and Therapy |
spelling | doaj.art-f612e3739b264402aab2a294be1d5d242024-03-31T11:27:24ZengAdis, Springer HealthcareInfectious Diseases and Therapy2193-82292193-63822024-03-0113343944510.1007/s40121-024-00941-2Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from FranceElise Foudrat0Sophie Caillard1Patient authorDepartment of Nephrology, Dialysis and Transplantation, INSERM U 1109, LabEx TRANSPLANTEX, Strasbourg University Hospital-Nouvel Hôpital CivilAbstract This article is co-authored by a kidney transplant recipient and her nephrologist. By sharing her personal experience of the coronavirus disease 2019 (COVID-19) pandemic, the patient illustrates the concerns of immunocompromised patients during this unprecedented health crisis. She describes the difficulties encountered at work, the omnipresent protective measures, and the need for appropriate information. The nephrologist, who follows a cohort of over 1700 kidney transplant recipients, recounts the medical team’s struggle to protect their vulnerable patients against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as a veritable succession of hopes and disappointments. She describes the management of immunosuppression in kidney transplant recipients, the deployment of the COVID-19 vaccination program with the finding of poor immune responses in many patients including those receiving immunosuppressant drugs after kidney transplant, and the first use of prophylactic monoclonal antibodies. From both the patient’s and the physician’s perspectives, the COVID-19 pandemic has required continuous adaptation.https://doi.org/10.1007/s40121-024-00941-2COVID-19Immunosuppressive drugKidney transplantPatient’s perspectiveProphylactic monoclonal antibodiesSARS-CoV-2 vaccine |
spellingShingle | Elise Foudrat Sophie Caillard Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France Infectious Diseases and Therapy COVID-19 Immunosuppressive drug Kidney transplant Patient’s perspective Prophylactic monoclonal antibodies SARS-CoV-2 vaccine |
title | Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France |
title_full | Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France |
title_fullStr | Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France |
title_full_unstemmed | Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France |
title_short | Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France |
title_sort | living during covid 19 while immunocompromised a patient and physician perspective from france |
topic | COVID-19 Immunosuppressive drug Kidney transplant Patient’s perspective Prophylactic monoclonal antibodies SARS-CoV-2 vaccine |
url | https://doi.org/10.1007/s40121-024-00941-2 |
work_keys_str_mv | AT elisefoudrat livingduringcovid19whileimmunocompromisedapatientandphysicianperspectivefromfrance AT sophiecaillard livingduringcovid19whileimmunocompromisedapatientandphysicianperspectivefromfrance |